Complement factor H and related proteins in age-related macular degeneration

Comptes Rendus - Biologies

Volumn 337, Issue 3, 2014, Pages 178-184

  Calippe, Bertrand ^a,b,c   Guillonneau, Xavier ^a,b,c   Sennlaub, Florian ^a,b,c  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

Author keywords

Age related macular degeneration; Complement Factor H; Protective haplotypes

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C5; COMPLEMENT FACTOR H; COMPLEMENT FACTOR H RELATED PROTEIN; COMPLEMENT FACTOR H RELATED PROTEIN 1; COMPLEMENT FACTOR H RELATED PROTEIN 3; UNCLASSIFIED DRUG;

AGE CLASS; LITERATURE REVIEW; MUTATION; POLYMORPHISM; PROTEIN;

ARTICLE; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; NONHUMAN; PROTEIN FUNCTION; PROTEIN STRUCTURE; RETINA MACULA AGE RELATED DEGENERATION;

AGE-RELATED MACULAR DEGENERATION; COMPLEMENT FACTOR H; DÉGÉNÉRESCENCE MACULAIRE LIÉE À L'ÂGE; FACTEUR COMPLÉMENT H; HAPLOTYPES PROTECTEURS; PROTECTIVE HAPLOTYPES;

AGING; BLOOD PROTEINS; COMPLEMENT C3B INACTIVATOR PROTEINS; COMPLEMENT FACTOR H; HUMANS; MACULAR DEGENERATION;

EID: 84897981952     PISSN: 16310691     EISSN: 17683238     Source Type: Journal    
DOI: 10.1016/j.crvi.2013.12.003     Document Type: Short Survey

References (70)

1. R. Klein, T. Peto, A. Bird, and M.R. Vannewkirk The epidemiology of age-related macular degeneration Am. J. Ophthalmol. 137 2004 486 495
2. S.H. Sarks Ageing and degeneration in the macular region: a clinico-pathological study Brit. J. Ophthalmol. 60 1976 324 341
3. S. Khandhadia, V. Cipriani, J.R. Yates, and A.J. Lotery Age-related macular degeneration and the complement system Immunobiology 217 2012 127 146
4. A.O. Edwards, R. Ritter 3rd, K.J. Abel, A. Manning, and C. Panhuysen et al. Complement factor H polymorphism and age-related macular degeneration Science 308 2005 421 424
5. G.S. Hageman, D.H. Anderson, L.V. Johnson, L.S. Hancox, and A.J. Taiber et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration Proc. Natl. Acad. Sci. U S A 102 2005 7227 7232
6. J.L. Haines, M.A. Hauser, S. Schmidt, W.K. Scott, and L.M. Olson et al. Complement factor H variant increases the risk of age-related macular degeneration Science 308 2005 419 421
7. R.J. Klein, C. Zeiss, E.Y. Chew, J.Y. Tsai, and R.S. Sackler et al. Complement factor H polymorphism in age-related macular degeneration Science 308 2005 385 389
8. P.F. Zipfel, C. Skerka, J. Hellwage, S.T. Jokiranta, and S. Meri et al. Factor H family proteins: on complement, microbes and human diseases Biochem. Soc. Trans. 30 2002 971 978
9. A.E. Hughes, N. Orr, H. Esfandiary, M. Diaz-Torres, and T. Goodship et al. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration Nat. Genet. 38 2006 1173 1177
10. L.G. Fritsche, N. Lauer, A. Hartmann, S. Stippa, and C.N. Keilhauer et al. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD) Hum. Mol. Genet. 19 2010 4694 4704
11. R. Flierman, and M.R. Daha The clearance of apoptotic cells by complement Immunobiology 212 2007 363 370
12. D. Ricklin, G. Hajishengallis, K. Yang, and J.D. Lambris Complement: a key system for immune surveillance and homeostasis Nat. Immunol. 11 2010 785 797
13. D.H. Anderson, M.J. Radeke, N.B. Gallo, E.A. Chapin, and P.T. Johnson et al. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited Prog. Retin. Eye Res. 29 2010 95 112
14. E.L. Gautier, T. Shay, J. Miller, M. Greter, and C. Jakubzick et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages Nat. Immunol. 13 2012 1118 1128
15. C. Luo, M. Chen, and H. Xu Complement gene expression and regulation in mouse retina and retinal pigment epithelium/choroid Mol. Vis. 17 2011 1588 1597
16. W. Ma, L.X. Qin, F.T. Liu, Z. Gu, and J. Wang et al. Ubiquinone-quantum dot bioconjugates for in vitro and intracellular complex I sensing Sci. Rep. 3 2013 1537
17. G. Schlaf, T. Demberg, N. Beisel, H.L. Schieferdecker, and O. Gotze Expression and regulation of complement factors H and I in rat and human cells: some critical notes Mol. Immunol. 38 2001 231 239
18. M.R. Griffiths, J.W. Neal, M. Fontaine, T. Das, and P. Gasque Complement factor H, a marker of self protects against experimental autoimmune encephalomyelitis J. Immunol. 182 2009 4368 4377
19. J. Alsenz, J.D. Lambris, T.F. Schulz, and M.P. Dierich Localization of the complement-component-C3b-binding site and the cofactor activity for factor I in the 38 kDa tryptic fragment of factor H Biochem. J. 224 1984 389 398
20. S. Kuhn, and P.F. Zipfel Mapping of the domains required for decay acceleration activity of the human factor H-like protein 1 and factor H Eur. J. Immunol. 26 1996 2383 2387
21. V.M. Avery, and D.L. Gordon Characterization of factor H binding to human polymorphonuclear leukocytes J. Immunol. 151 1993 5545 5553
22. J. Losse, P.F. Zipfel, and M. Jozsi Factor H and factor H-related protein 1 bind to human neutrophils via complement receptor 3 mediate attachment to Candida albicans, and enhance neutrophil antimicrobial activity J. Immunol. 184 2010 912 921
23. T.S. Jokiranta, P.F. Zipfel, J. Hakulinen, S. Kuhn, and M.K. Pangburn et al. Analysis of the recognition mechanism of the alternative pathway of complement by monoclonal anti-factor H antibodies: evidence for multiple interactions between H and surface bound C3b FEBS Lett. 393 1996 297 302
24. E. Giannakis, T.S. Jokiranta, D.A. Male, S. Ranganathan, and R.J. Ormsby et al. A common site within factor H SCR 7 responsible for binding heparin C-reactive protein and streptococcal M protein Eur. J. Immunol. 33 2003 962 969
25. M. Mihlan, S. Stippa, M. Jozsi, and P.F. Zipfel Monomeric CRP contributes to complement control in fluid phase and on cellular surfaces and increases phagocytosis by recruiting factor H Cell Death Differ. 16 2009 1630 1640
26. D. Weismann, K. Hartvigsen, N. Lauer, K.L. Bennett, and H.P. Scholl et al. Complement factor H binds malondialdehyde epitopes and protects from oxidative stress Nature 478 2011 76 81
27. A.K. Sharma, and M.K. Pangburn Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis Proc. Natl. Acad. Sci. U S A 93 1996 10996 11001
28. T.K. Blackmore, J. Hellwage, T.A. Sadlon, N. Higgs, and P.F. Zipfel et al. Identification of the second heparin-binding domain in human complement factor H J. Immunol. 160 1998 3342 3348
29. S.J. Clark, V.A. Higman, B. Mulloy, S.J. Perkins, and S.M. Lea et al. His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form J. Biol. Chem. 281 2006 24713 24720
30. S. Kuhn, C. Skerka, and P.F. Zipfel Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1 J. Immunol. 155 1995 5663 5670
31. E. Goicoechea de Jorge, J.J. Caesar, T.H. Malik, M. Patel, and M. Colledge et al. Dimerization of complement factor H-related proteins modulates complement activation in vivo Proc. Natl. Acad. Sci. U S A 110 2013 4685 4690
32. M.C. Pickering, H.T. Cook, J. Warren, A.E. Bygrave, and J. Moss et al. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H Nat. Genet. 31 2002 424 428
33. C. Timmann, M. Leippe, and R.D. Horstmann Two major serum components antigenically related to complement factor H are different glycosylation forms of a single protein with no factor H-like complement regulatory functions J. Immunol. 146 1991 1265 1270
34. S. Heinen, A. Hartmann, N. Lauer, U. Wiehl, and H.M. Dahse et al. Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation Blood 114 2009 2439 2447
35. C.C. Klaver, R.C. Wolfs, J.J. Assink, C.M. van Duijn, and A. Hofman et al. Genetic risk of age-related maculopathy population-based familial aggregation study Arch. Ophthalmol. 116 1998 1646 1651
36. M. Uyama, K. Takahashi, N. Ida, M. Miyashiro, and A. Ando et al. The second eye of Japanese patients with unilateral exudative age related macular degeneration Brit. J. Ophthalmol. 84 2000 1018 1023
37. N. Gotoh, R. Yamada, H. Hiratani, V. Renault, and S. Kuroiwa et al. No association between complement factor H gene polymorphism and exudative age-related macular degeneration in Japanese Hum. Genet. 120 2006 139 143
38. K. Mori, K. Horie-Inoue, P.L. Gehlbach, H. Takita, and S. Kabasawa et al. Phenotype and genotype characteristics of age-related macular degeneration in a Japanese population Ophthalmology 117 2010 928 938
39. K.P. Magnusson, S. Duan, H. Sigurdsson, H. Petursson, and Z. Yang et al. CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD PLoS Med. 3 2006 e5
40. D.D. Despriet, C.C. Klaver, J.C. Witteman, A.A. Bergen, and I. Kardys et al. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration JAMA 296 2006 301 309
41. C.L. Thompson, B.E. Klein, R. Klein, Z. Xu, and J. Capriotti et al. Complement factor H and hemicentin-1 in age-related macular degeneration and renal phenotypes Hum. Mol. Genet. 16 2007 2135 2148
42. Y. Yu, R. Reynolds, B. Rosner, M.J. Daly, and J.M. Seddon Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models Invest. Ophthalmol. Vis. Sci. 53 2012 1548 1556
43. L.G. Fritsche, W. Chen, M. Schu, B.L. Yaspan, and Y. Yu et al. Seven new loci associated with age-related macular degeneration Nat. Genet. 45 2013 433 439 439e431-432
44. J.M. Seddon, P.J. Francis, S. George, D.W. Schultz, and B. Rosner et al. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration JAMA 297 2007 1793 1800
45. P.X. Shaw, L. Zhang, M. Zhang, H. Du, and L. Zhao et al. Complement factor H genotypes impact risk of age-related macular degeneration by interaction with oxidized phospholipids Proc. Natl. Acad. Sci. U S A 109 2012 13757 13762
46. M. Li, P. Atmaca-Sonmez, M. Othman, K.E. Branham, and R. Khanna et al. CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration Nat. Genet. 38 2006 1049 1054
47. S. Raychaudhuri, O. Iartchouk, K. Chin, P.L. Tan, and A.K. Tai et al. A rare penetrant mutation in CFH confers high risk of age-related macular degeneration Nat. Genet. 43 2011 1232 1236
48. M. Jozsi, S. Heinen, A. Hartmann, C.W. Ostrowicz, and S. Halbich et al. Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions J. Am. Soc. Nephrol. 17 2006 170 177
49. A. Tortajada, T. Montes, R. Martinez-Barricarte, B.P. Morgan, and C.L. Harris et al. The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity Hum. Mol. Genet. 18 2009 3452 3461
50. G.S. Hageman, L.S. Hancox, A.J. Taiber, K.M. Gehrs, and D.H. Anderson et al. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications Ann. Med. 38 2006 592 604
51. K.L. Spencer, M.A. Hauser, L.M. Olson, S. Schmidt, and W.K. Scott et al. Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration Hum. Mol. Genet. 17 2008 971 977
52. J.A. Fagerness, J.B. Maller, B.M. Neale, R.C. Reynolds, and M.J. Daly et al. Variation near complement factor I is associated with risk of advanced AMD Eur. J. Hum. Genet. 17 2009 100 104
53. B. Gold, J.E. Merriam, J. Zernant, L.S. Hancox, and A.J. Taiber et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration Nat. Genet. 38 2006 458 462
54. J.B. Maller, J.A. Fagerness, R.C. Reynolds, B.M. Neale, and M.J. Daly et al. Variation in complement factor 3 is associated with risk of age-related macular degeneration Nat. Genet. 39 2007 1200 1201
55. S. Sivaprasad, T. Adewoyin, T.A. Bailey, S.S. Dandekar, and S. Jenkins et al. Estimation of systemic complement C3 activity in age-related macular degeneration Arch. Ophthalmol. 125 2007 515 519
56. R. Reynolds, M.E. Hartnett, J.P. Atkinson, P.C. Giclas, and B. Rosner et al. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes Invest. Ophthalmol. Vis. Sci. 50 2009 5818 5827
57. H.P. Scholl, P. Charbel Issa, M. Walier, S. Janzer, and B. Pollok-Kopp et al. Systemic complement activation in age-related macular degeneration PLoS One 3 2008 e2593
58. M. Heurich, R. Martinez-Barricarte, N.J. Francis, D.L. Roberts, and S. Rodriguez de Cordoba et al. Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk Proc. Natl. Acad. Sci. U S A 108 2011 8761 8766
59. K.M. Loyet, L.E. Deforge, K.J. Katschke Jr., L. Diehl, and R.R. Graham et al. Activation of the alternative complement pathway in vitreous is controlled by genetics in age-related macular degeneration Invest. Ophthalmol. Vis. Sci. 53 2012 6628 6637
60. R.F. Mullins, S.R. Russell, D.H. Anderson, and G.S. Hageman Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease FASEB J. 14 2000 835 846
61. S. Khandhadia, S. Hakobyan, L.Z. Heng, J. Gibson, and D.H. Adams et al. Age-related macular degeneration and modification of systemic complement factor H production through liver transplantation Ophthalmology 2013
62. J. Esparza-Gordillo, J.M. Soria, A. Buil, L. Almasy, and J. Blangero et al. Genetic and environmental factors influencing the human factor H plasma levels Immunogenetics 56 2004 77 82
63. S. Hakobyan, C.L. Harris, A. Tortajada, E. Goicochea de Jorge, and A. Garcia-Layana et al. Measurement of factor H variants in plasma using variant-specific monoclonal antibodies: application to assessing risk of age-related macular degeneration Invest. Ophthalmol. Vis. Sci. 49 2008 1983 1990
64. P.T. Johnson, K.E. Betts, M.J. Radeke, G.S. Hageman, and D.H. Anderson et al. Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid Proc. Natl. Acad. Sci. U S A 103 2006 17456 17461
65. T. Manuelian, J. Hellwage, S. Meri, J. Caprioli, and M. Noris et al. Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome J. Clin. Invest. 111 2003 1181 1190
66. S.J. Clark, L.A. Ridge, A.P. Herbert, S. Hakobyan, and B. Mulloy et al. Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions J. Immunol. 190 2013 2049 2057
67. M. Kliffen, C.M. Mooy, T.M. Luider, J.G. Huijmans, and S. Kerkvliet et al. Identification of glycosaminoglycans in age-related macular deposits Arch. Ophthalmol. 114 1996 1009 1014
68. P.J. Coffey, C. Gias, C.J. McDermott, P. Lundh, and M.C. Pickering et al. Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction Proc. Natl. Acad. Sci. U S A 104 2007 16651 16656
69. V.V. Lyzogubov, R.G. Tytarenko, P. Jha, J. Liu, and N.S. Bora et al. Role of ocular complement factor H in a murine model of choroidal neovascularization Am. J. Pathol. 177 2010 1870 1880
70. R.L. Ufret-Vincenty, B. Aredo, X. Liu, A. McMahon, and P.W. Chen et al. Transgenic mice expressing variants of complement factor H develop AMD-like retinal findings Invest. Ophthalmol. Vis. Sci. 51 2012 5878 5887